In 2019, the EULAR/ACR criteria emphasized the specificity and overall structure of antinuclear antibodies (ANA) as mandatory entry criteria for the diagnosis of SLE and LN [54]. The gene discussed is BTG3; the disease is systemic lupus erythematosus.